To include your compound in the COVID-19 Resource Center, submit it here.

Cubist, Gilead sales and marketing update

CBST granted GILD exclusive European marketing rights to its Cidecin daptomycin

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE